
₹100.00
Might PG-2 is a triple-combination diabetes tablet containing Glimepiride, Pioglitazone, and Metformin Hydrochloride. It helps control blood sugar levels in adults with Type 2 diabetes through three different mechanisms. This medicine is prescribed when single or dual therapy is not sufficient to manage blood glucose.
Might PG-2 is a combination antidiabetic tablet containing Glimepiride, Pioglitazone, and Metformin Hydrochloride. It is used to manage blood sugar levels in adults with Type 2 diabetes mellitus. This triple-action formula works through different pathways to provide comprehensive glucose control.
Glimepiride stimulates the pancreas to release more insulin. Pioglitazone makes body tissues more sensitive to insulin so glucose is used more effectively. Metformin reduces the liver's glucose production and improves how the body absorbs sugar from food. Together, they manage blood sugar from three angles.
(Check with your Doctor if any of these side effects persist or worry you.)
When using this product, you will need a prescription. Administer only by the direction of a clinical master. Do not self-medicate.